Hormone | Number of cases/number of controls | Unadjusted | Adjusted | ||||
---|---|---|---|---|---|---|---|
 |  | OR | (95% CI) | P b | OR | (95% CI) | P b |
All participants | Â | Â | Â | Â | Â | Â | Â |
Estradiol | Â | Â | Â | 0.62 | Â | Â | 0.48 |
   5-54 pg/ml | 22/45 | 1.0 |  |  | 1.0 |  |  |
   55-94 pg/ml | 28/37 | 1.7 | (0.8 to 3.6) |  | 1.9 | (0.8 to 4.6) |  |
   95-138 pg/ml | 24/43 | 1.2 | (0.6 to 2.5) |  | 1.1 | (0.5 to 2.5) |  |
   139-497 pg/ml | 24/43 | 1.1 | (0.5 to 2.2) |  | 1.4 | (0.6 to 3.4) |  |
Bioavailable estradiol | Â | Â | Â | 0.46 | Â | Â | 0.38 |
   1.5-31.3 pg/ml | 23/43 | 1.0 |  |  | 1.0 |  |  |
   31.6-54.9 pg/ml | 25/42 | 1.2 | (0.6 to 2.5) |  | 1.2 | (0.5 to 2.8) |  |
   55.0-79.2 pg/ml | 26/41 | 1.2 | (0.6 to 2.6) |  | 1.2 | (0.5 to 2.8) |  |
   79.3-302.4 pg/ml | 24/42 | 1.1 | (0.5 to 2.2) |  | 1.3 | (0.5 to 3.1) |  |
Follicular c | Â | Â | Â | Â | Â | Â | Â |
Estradiol | Â | Â | Â | 0.52 | Â | Â | 0.69 |
   5-54 pg/ml | 10/22 | 1.0 |  |  | 1.0 |  |  |
   56-108 pg/ml | 13/21 | 1.5 | (0.5 to 4.3) |  | 2.4 | (0.6 to 10.6) |  |
   110-480 pg/ml | 12/21 | 1.4 | (0.4 to 4.2) |  | 1.4 | (0.3 to 6.5) |  |
Bioavailable estradiol | Â | Â | Â | 0.51 | Â | Â | 0.70 |
   1.5-31.7 pg/ml | 12/21 | 1.0 |  |  | 1.0 |  |  |
   32.2-62.9 pg/ml | 8/25 | 0.6 | (0.2 to 1.9) |  | 0.7 | (0.1 to 3.1) |  |
   63.5-264.2 pg/ml | 15/18 | 1.8 | (0.6 to 5.8) |  | 2.0 | (0.5 to 8.3) |  |
Luteal d | Â | Â | Â | Â | Â | Â | Â |
Estradiol | Â | Â | Â | 0.49 | Â | Â | 0.62 |
   6-78 pg/ml | 10/24 | 1.0 |  |  | 1.0 |  |  |
   80-114 pg/ml | 16/18 | 2.0 | (0.7 to 5.8) |  | 2.3 | (0.6 to 9.2) |  |
   115-299 pg/ml | 11/23 | 1.2 | (0.4 to 3.2) |  | 1.3 | (0.4 to 4.3) |  |
Bioavailable estradiol | Â | Â | Â | 0.29 | Â | Â | 0.51 |
   3.5-48.4 pg/ml | 9/25 | 1.0 |  |  | 1.0 |  |  |
   48.8-67.9 pg/ml | 15/19 | 2.1 | (0.7 to 6.0) |  | 2.5 | (0.6 to 10.5) |  |
   68.2-184.6 pg/ml | 13/21 | 1.6 | (0.6 to 4.4) |  | 1.8 | (0.6 to 5.8) |  |